References
- Ahmenn F. A reassessment of the clinical implications of the superior vena caval syndrome. J Clin Oncol 1984; 2: 961–969.
- Schraufnagel DE, Hill R, Leech JA, Pare JAP. Superior vena caval obstruction: is it a medical emergency? Am J Med 1981; 70: 1169-1174.
- Lewis RJ, Sisler GE, Mackenzie JW. Mediastinoscopy in advanced superior vena cava obstruction. Ann Thorac Surg 1981; 32: 458–462.
- Sculier JP, Evans WK, Feld R, et al. Superior vena caval obstruction syndrome in small cell lung cancer. Cancer 1986; 57: 847–851.
- Abid SH, Malhoyra V, Perry MC. Radiation-induced and chemotherapy-induced pulmonary injury. Curr Opin Oncol 2001; 13 (4): 242–248.
- Junker K, Thomas M, Schulmann K, Klinke F, Bosse U, Muller KM. Tumor regression in non-small-cell lung cancer fol-lowing neoadjuvant therapy. Histological assessment. J Cancer Res Clin Oncol 1997; 123 (9): 469–477.
- Yara S, Kawakami K, Kudeken N, et al. FTS reduces bleomycin-induced cytokine and chemokine production and inhibits pulmonary fibrosis in mice. Clin Exp Immunol 2001; 124 (1): 77–85.
- Solomon N, Wholey MH, Jarmolowski CR. Intravascular stents in the management of superior vena cava syndrome. Cath Cardiovasc Diagn 1991; 23: 245–252.